MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Consolidator ... Mass Market Scale-up, Global Reach, Public Capital
Consolidators: BioPharmaceuticals
Eli Lilly and Company (NYSE: LLY)*
*Key People: Eli Lilly
Parents
*Key People: Clinical Trials, Pharmacovigilance, Consent
*Key People: Indiana
*Key People: Industry
*Key People: Industry (Medical)
Eli Lilly and Company (NYSE: LLY)*
Children
600 part time nurse drug trainers for diabetes
Avnish Kapoor, PHD DIRECTOR, EMERGING TECHNOLOGY & INNOVATION - CAMBRIDGE, ELI LILLY AND COMPANY (2021
Dan Skovronsky Chief scientific officer, Eli Lilly (2020)
Daniel Skovronsky, M.D., Ph.D. Chief Scientific Officer and President of Lilly Research Laboratories and Lilly Immunology (2025)
David Hyman, M.D., Lilly’s chief medical officer (2025)
David Ricks Chairman & CEO, Eli Lilly (2025)
Dr Randall Tobias - Director, Foreign Assistance, State Department
Ed Sagebiel, spokesman for corporate matters for Eli Lilly & Co
Gail Cassell, Eli Lilly & Company, Vice President of Infectious Diseases
Gerhard Mayr, EVP, Eli Lilly
Jacob Van Naarden, president of Eli Lilly oncology business (2024)
Jeff Emmick, M.D., Ph.D., senior vice president of product development, Eli Lilly (2024)
John Lechleiter, CEO, Eli Lilly & Co.(2015)
Laura Steele Senior Vice President, US Neuroscience, Eli Lilly and Company (2024)
Musaddiq Khan Director, Clinical Program Operations at Eli Lilly and Company (2021)
Number of employees: 39,000 (2022)
Number of employees: 43,000 (2023)
Selina Estwick Manager- Lilly Research Labs, Technical Transfer & Due Diligence Eli Lilly (2021)
Sidney Taurel, Chairman, Eli Lilly
Stephen Ruberg, senior research fellow at Eli Lilly & Company
Jumps
Dr. Jeffrey Sevigny, Chief Medical Officer, Rapport (2025)
Finance & Acquisitions: Eli Lilly
Mitchell Daniels, Governor, Indiana
Organization & Developments: Eli Lilly